GTR 90916050
Grants Notice For Method To Extend Research In Time (Merit) Award Extension Request (Type 4 Esubmission Clinical Trial Optional
ICB — International Competitive Bid
Closes Sep 07, 2028
Americas
Tender Information
GTR Reference
90916050
Tendering Authority
Subscribe to view
Tender No
PAR-25-324
Financer Name
Self-Funded
Work Title
Grants Notice For Method To Extend Research In Time (Merit) Award Extension Request (Type 4 Esubmission Clinical Trial Optional
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Americas
Political Region
Asia-Pacific Economic Cooperation, APEC,APAC (Asia Pacific)
Last Date of Bid Submission
07-09-2028
Work Detail
Grants Notice For Method To Extend Research In Time (Merit) Award Extension Request (Type 4 Esubmission Clinical Trial Optional The National Cancer Institute (Nci) Method To Extend Research In Time (Merit) (R37) Award Provides Extended Grant Support To Early Stage Investigators (Esis). By Providing Such An Opportunity For Longer Term Support To Esis, The Nci Intends To Offer Flexibility And Opportunity For Creativity And Innovation And Additional Time To Successfully Launch Their Careers And To Become More Established Before Having To Submit Renewal Applications (Not-Ca-18-037). The Objective Of The Ncis Esi Merit Award Is To Allow Eligible Investigators The Opportunity To Obtain Up To 7 Years Of Support In Two Seg
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
fbb91bf6-3fde-4b6b-9259-985ab94ce78f.htm
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.